MitraClip in Asia　- Current Adoption and Regional Data

Area of Science:

• Cardiovascular Medicine
• Interventional Cardiology
• Medical Device Technology

Background:

• Percutaneous edge-to-edge mitral valve repair using the MitraClip device is established for severe degenerative mitral regurgitation in high-risk surgical patients in the US and Europe.
• Recent trials show benefits of MitraClip in select functional mitral regurgitation patients.
• Over 80,000 MitraClip procedures have been performed globally, yet adoption in Asia is slower, with limited published data on Asian populations.

Purpose of the Study:

• To review the Asian experience with the MitraClip device.
• To identify and discuss challenges associated with MitraClip adoption and use in Asian patient populations.

Main Methods:

• Literature review of studies and publications detailing MitraClip use in Asian populations.
• Analysis of adoption rates and clinical outcomes reported in Asian cohorts.
• Identification of specific challenges encountered in the Asian healthcare context.

Main Results:

• MitraClip adoption in Asia has been gradual compared to Western countries.
• Limited published data exists on the efficacy and safety of MitraClip in diverse Asian populations.
• Specific challenges may include healthcare infrastructure, patient selection criteria, and physician training.

Conclusions:

• Further research and data collection are needed to understand the full potential and challenges of MitraClip in Asia.
• Addressing the identified challenges is crucial for expanding the benefits of MitraClip to Asian patients with mitral regurgitation.